These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28082817)

  • 1. Prevalence of upper gastrointestinal bleeding risk factors among the general population and osteoarthritis patients.
    Kim SH; Yun JM; Chang CB; Piao H; Yu SJ; Shin DW
    World J Gastroenterol; 2016 Dec; 22(48):10643-10652. PubMed ID: 28082817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of Helicobacter pylori infection to the risk of peptic ulcer bleeding in patients on nonsteroidal anti-inflammatory drugs, antiplatelet agents, anticoagulants, corticosteroids and selective serotonin reuptake inhibitors.
    Venerito M; Schneider C; Costanzo R; Breja R; Röhl FW; Malfertheiner P
    Aliment Pharmacol Ther; 2018 Jun; 47(11):1464-1471. PubMed ID: 29655196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent trends of hospitalizations for upper and lower gastrointestinal bleeding based on population prescriptions of aspirin, proton pump inhibitors and Helicobacter pylori eradication therapy: Trends of upper and lower gastrointestinal bleeding.
    Guo CG; Zhang F; Wu JT; Cheung KS; Li B; Law SYK; Leung WK
    United European Gastroenterol J; 2021 Jun; 9(5):543-551. PubMed ID: 33956403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors of gastrointestinal bleeding in clopidogrel users: a nationwide population-based study.
    Lin CC; Hu HY; Luo JC; Peng YL; Hou MC; Lin HC; Lee FY
    Aliment Pharmacol Ther; 2013 Nov; 38(9):1119-28. PubMed ID: 24099473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori and bleeding duodenal ulcer: prevalence of the infection and role of non-steroidal anti-inflammatory drugs.
    Gisbert JP; Gonzalez L; de Pedro A; Valbuena M; Prieto B; Llorca I; Briz R; Khorrami S; Garcia-Gravalos R; Pajares JM
    Scand J Gastroenterol; 2001 Jul; 36(7):717-24. PubMed ID: 11444470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of ulcer bleeding risk factors in dual antiplatelet-treated patients after percutaneous coronary intervention.
    Jensen BE; Hansen JM; Junker AB; Lassen JF; Jensen SE; Schaffalitzky de Muckadell OB
    Dan Med J; 2015 Jun; 62(6):. PubMed ID: 26036886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and Risk Factors for Upper Gastrointestinal Bleeding.
    Tielleman T; Bujanda D; Cryer B
    Gastrointest Endosc Clin N Am; 2015 Jul; 25(3):415-28. PubMed ID: 26142028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for peptic ulcer bleeding in terms of Helicobacter pylori, NSAIDs, and antiplatelet agents.
    Kang JM; Kim N; Lee BH; Park HK; Jo HJ; Shin CM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Jung HC; Song IS
    Scand J Gastroenterol; 2011 Nov; 46(11):1295-301. PubMed ID: 21815866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The incidence, clinical characteristics and risk factors of upper gastrointestinal bleeding in patients taking dual antiplatelet therapy after percutaneous coronary intervention in south China].
    Zhang ZF; Sha WH; Tan GY; Wang QY
    Zhonghua Nei Ke Za Zhi; 2016 Jun; 55(6):445-50. PubMed ID: 27256606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for upper gastrointestinal bleeding among aspirin users: An old issue with new findings from a population-based cohort study.
    Luo PJ; Lin XH; Lin CC; Luo JC; Hu HY; Ting PH; Hou MC
    J Formos Med Assoc; 2019 May; 118(5):939-944. PubMed ID: 30366771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specifics of Helicobacter pylori infection/NSAID effects in the elderly.
    Davidovic M; Svorcan P; Milanovic P; Antovic A; Milosevic D
    Rom J Gastroenterol; 2005 Sep; 14(3):253-8. PubMed ID: 16200236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comorbidities affect risk of nonvariceal upper gastrointestinal bleeding.
    Crooks CJ; West J; Card TR
    Gastroenterology; 2013 Jun; 144(7):1384-93, 1393.e1-2; quiz e18-9. PubMed ID: 23470619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks of hospitalization for upper gastrointestinal bleeding in users of selective serotonin reuptake inhibitors after Helicobacter pylori eradication therapy: a propensity score matching analysis.
    Guo CG; Cheung KS; Zhang F; Chan EW; Chen L; Wong ICK; Leung WK
    Aliment Pharmacol Ther; 2019 Nov; 50(9):1001-1008. PubMed ID: 31583734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations.
    Lanas A; García-Rodríguez LA; Arroyo MT; Gomollón F; Feu F; González-Pérez A; Zapata E; Bástida G; Rodrigo L; Santolaria S; Güell M; de Argila CM; Quintero E; Borda F; Piqué JM;
    Gut; 2006 Dec; 55(12):1731-8. PubMed ID: 16687434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alendronate, a bisphosphonate, increased upper and lower gastrointestinal bleeding: risk factor analysis from a nationwide population-based study.
    Peng YL; Hu HY; Luo JC; Hou MC; Lin HC; Lee FY
    Osteoporos Int; 2014 May; 25(5):1617-23. PubMed ID: 24566586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of peptic ulcer bleeding associated with Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs, low-dose aspirin, and antihypertensive drugs: a case-control study.
    Nagata N; Niikura R; Sekine K; Sakurai T; Shimbo T; Kishida Y; Tanaka S; Aoki T; Okubo H; Watanabe K; Yokoi C; Akiyama J; Yanase M; Mizokami M; Uemura N
    J Gastroenterol Hepatol; 2015 Feb; 30(2):292-8. PubMed ID: 25339607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case-control study of the risk of upper gastrointestinal mucosal injuries in patients prescribed concurrent NSAIDs and antithrombotic drugs based on data from the Japanese national claims database of 13 million accumulated patients.
    Sugisaki N; Iwakiri R; Tsuruoka N; Sakata Y; Shimoda R; Fujimoto S; Eguchi Y; Fujimoto K
    J Gastroenterol; 2018 Dec; 53(12):1253-1260. PubMed ID: 29948304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of peptic ulcer perforation in Korea.
    Yang YJ; Bang CS; Shin SP; Park TY; Suk KT; Baik GH; Kim DJ
    World J Gastroenterol; 2017 Apr; 23(14):2566-2574. PubMed ID: 28465641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of hospitalization for upper gastrointestinal bleeding in Helicobacter pylori eradicated patients newly started on warfarin or direct oral anticoagulants: A population-based cohort study.
    Jiang F; Ju C; Guo CG; Cheung KS; Li B; Law SYK; Lau WCY; Leung WK
    Helicobacter; 2023 Aug; 28(4):e12990. PubMed ID: 37246782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.
    Voutilainen M; Mäntynen T; Färkkilä M; Juhola M; Sipponen P
    Scand J Gastroenterol; 2001 Aug; 36(8):817-21. PubMed ID: 11495076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.